0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Clotting Factor Market Research Report 2024
Published Date: March 2024
|
Report Code: QYRE-Auto-29A1661
Home | Market Reports | Health| Nutrition
Global Clotting Factor Market Insights and Forecast to 2028
BUY CHAPTERS

Global Clotting Factor Market Research Report 2024

Code: QYRE-Auto-29A1661
Report
March 2024
Pages:74
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Clotting Factor Market Size

The global Clotting Factor market was valued at US$ 1453.6 million in 2023 and is anticipated to reach US$ 2022 million by 2030, witnessing a CAGR of 4.8% during the forecast period 2024-2030.

Clotting Factor Market

Clotting Factor Market

Coagulation factors are various protein components involved in blood coagulation. Its physiological function is to be activated when blood vessels bleed, stick to platelets and plug leaks in blood vessels.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Clotting Factor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clotting Factor.

Report Scope

The Clotting Factor market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Clotting Factor market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Clotting Factor companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Clotting Factor Market Report

Report Metric Details
Report Name Clotting Factor Market
Accounted market size in 2023 US$ 1453.6 million
Forecasted market size in 2030 US$ 2022 million
CAGR 4.8%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Clotting Factor I
  • Clotting Factor II
  • Clotting Factor III
  • Clotting Factor IV
  • Others
Segment by Application
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Amgen, Novartis, Baxter, Britannia, Capricor, CSL Behring, GlaxoSmithKline, Grifol, Eli Lilly
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Clotting Factor companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Clotting Factor Market growing?

Ans: The Clotting Factor Market witnessing a CAGR of 4.8% during the forecast period 2024-2030.

What is the Clotting Factor Market size in 2030?

Ans: The Clotting Factor Market size in 2030 will be US$ 2022 million.

Who are the main players in the Clotting Factor Market report?

Ans: The main players in the Clotting Factor Market are Amgen, Novartis, Baxter, Britannia, Capricor, CSL Behring, GlaxoSmithKline, Grifol, Eli Lilly

What are the Application segmentation covered in the Clotting Factor Market report?

Ans: The Applications covered in the Clotting Factor Market report are Hospitals, Clinics, Ambulatory Surgical Centers

What are the Type segmentation covered in the Clotting Factor Market report?

Ans: The Types covered in the Clotting Factor Market report are Clotting Factor I, Clotting Factor II, Clotting Factor III, Clotting Factor IV, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clotting Factor Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Clotting Factor I
1.2.3 Clotting Factor II
1.2.4 Clotting Factor III
1.2.5 Clotting Factor IV
1.2.6 Others
1.3 Market by Application
1.3.1 Global Clotting Factor Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Clotting Factor Market Perspective (2019-2030)
2.2 Clotting Factor Growth Trends by Region
2.2.1 Global Clotting Factor Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Clotting Factor Historic Market Size by Region (2019-2024)
2.2.3 Clotting Factor Forecasted Market Size by Region (2025-2030)
2.3 Clotting Factor Market Dynamics
2.3.1 Clotting Factor Industry Trends
2.3.2 Clotting Factor Market Drivers
2.3.3 Clotting Factor Market Challenges
2.3.4 Clotting Factor Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clotting Factor Players by Revenue
3.1.1 Global Top Clotting Factor Players by Revenue (2019-2024)
3.1.2 Global Clotting Factor Revenue Market Share by Players (2019-2024)
3.2 Global Clotting Factor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Clotting Factor Revenue
3.4 Global Clotting Factor Market Concentration Ratio
3.4.1 Global Clotting Factor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clotting Factor Revenue in 2023
3.5 Clotting Factor Key Players Head office and Area Served
3.6 Key Players Clotting Factor Product Solution and Service
3.7 Date of Enter into Clotting Factor Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Clotting Factor Breakdown Data by Type
4.1 Global Clotting Factor Historic Market Size by Type (2019-2024)
4.2 Global Clotting Factor Forecasted Market Size by Type (2025-2030)
5 Clotting Factor Breakdown Data by Application
5.1 Global Clotting Factor Historic Market Size by Application (2019-2024)
5.2 Global Clotting Factor Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Clotting Factor Market Size (2019-2030)
6.2 North America Clotting Factor Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Clotting Factor Market Size by Country (2019-2024)
6.4 North America Clotting Factor Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Clotting Factor Market Size (2019-2030)
7.2 Europe Clotting Factor Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Clotting Factor Market Size by Country (2019-2024)
7.4 Europe Clotting Factor Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Clotting Factor Market Size (2019-2030)
8.2 Asia-Pacific Clotting Factor Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Clotting Factor Market Size by Region (2019-2024)
8.4 Asia-Pacific Clotting Factor Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Clotting Factor Market Size (2019-2030)
9.2 Latin America Clotting Factor Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Clotting Factor Market Size by Country (2019-2024)
9.4 Latin America Clotting Factor Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clotting Factor Market Size (2019-2030)
10.2 Middle East & Africa Clotting Factor Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Clotting Factor Market Size by Country (2019-2024)
10.4 Middle East & Africa Clotting Factor Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Detail
11.1.2 Amgen Business Overview
11.1.3 Amgen Clotting Factor Introduction
11.1.4 Amgen Revenue in Clotting Factor Business (2019-2024)
11.1.5 Amgen Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Clotting Factor Introduction
11.2.4 Novartis Revenue in Clotting Factor Business (2019-2024)
11.2.5 Novartis Recent Development
11.3 Baxter
11.3.1 Baxter Company Detail
11.3.2 Baxter Business Overview
11.3.3 Baxter Clotting Factor Introduction
11.3.4 Baxter Revenue in Clotting Factor Business (2019-2024)
11.3.5 Baxter Recent Development
11.4 Britannia
11.4.1 Britannia Company Detail
11.4.2 Britannia Business Overview
11.4.3 Britannia Clotting Factor Introduction
11.4.4 Britannia Revenue in Clotting Factor Business (2019-2024)
11.4.5 Britannia Recent Development
11.5 Capricor
11.5.1 Capricor Company Detail
11.5.2 Capricor Business Overview
11.5.3 Capricor Clotting Factor Introduction
11.5.4 Capricor Revenue in Clotting Factor Business (2019-2024)
11.5.5 Capricor Recent Development
11.6 CSL Behring
11.6.1 CSL Behring Company Detail
11.6.2 CSL Behring Business Overview
11.6.3 CSL Behring Clotting Factor Introduction
11.6.4 CSL Behring Revenue in Clotting Factor Business (2019-2024)
11.6.5 CSL Behring Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Detail
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Clotting Factor Introduction
11.7.4 GlaxoSmithKline Revenue in Clotting Factor Business (2019-2024)
11.7.5 GlaxoSmithKline Recent Development
11.8 Grifol
11.8.1 Grifol Company Detail
11.8.2 Grifol Business Overview
11.8.3 Grifol Clotting Factor Introduction
11.8.4 Grifol Revenue in Clotting Factor Business (2019-2024)
11.8.5 Grifol Recent Development
11.9 Eli Lilly
11.9.1 Eli Lilly Company Detail
11.9.2 Eli Lilly Business Overview
11.9.3 Eli Lilly Clotting Factor Introduction
11.9.4 Eli Lilly Revenue in Clotting Factor Business (2019-2024)
11.9.5 Eli Lilly Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Clotting Factor Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Clotting Factor I
    Table 3. Key Players of Clotting Factor II
    Table 4. Key Players of Clotting Factor III
    Table 5. Key Players of Clotting Factor IV
    Table 6. Key Players of Others
    Table 7. Global Clotting Factor Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Clotting Factor Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 9. Global Clotting Factor Market Size by Region (2019-2024) & (US$ Million)
    Table 10. Global Clotting Factor Market Share by Region (2019-2024)
    Table 11. Global Clotting Factor Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 12. Global Clotting Factor Market Share by Region (2025-2030)
    Table 13. Clotting Factor Market Trends
    Table 14. Clotting Factor Market Drivers
    Table 15. Clotting Factor Market Challenges
    Table 16. Clotting Factor Market Restraints
    Table 17. Global Clotting Factor Revenue by Players (2019-2024) & (US$ Million)
    Table 18. Global Clotting Factor Market Share by Players (2019-2024)
    Table 19. Global Top Clotting Factor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clotting Factor as of 2023)
    Table 20. Ranking of Global Top Clotting Factor Companies by Revenue (US$ Million) in 2023
    Table 21. Global 5 Largest Players Market Share by Clotting Factor Revenue (CR5 and HHI) & (2019-2024)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Clotting Factor Product Solution and Service
    Table 24. Date of Enter into Clotting Factor Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Clotting Factor Market Size by Type (2019-2024) & (US$ Million)
    Table 27. Global Clotting Factor Revenue Market Share by Type (2019-2024)
    Table 28. Global Clotting Factor Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 29. Global Clotting Factor Revenue Market Share by Type (2025-2030)
    Table 30. Global Clotting Factor Market Size by Application (2019-2024) & (US$ Million)
    Table 31. Global Clotting Factor Revenue Market Share by Application (2019-2024)
    Table 32. Global Clotting Factor Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 33. Global Clotting Factor Revenue Market Share by Application (2025-2030)
    Table 34. North America Clotting Factor Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 35. North America Clotting Factor Market Size by Country (2019-2024) & (US$ Million)
    Table 36. North America Clotting Factor Market Size by Country (2025-2030) & (US$ Million)
    Table 37. Europe Clotting Factor Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. Europe Clotting Factor Market Size by Country (2019-2024) & (US$ Million)
    Table 39. Europe Clotting Factor Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Asia-Pacific Clotting Factor Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 41. Asia-Pacific Clotting Factor Market Size by Region (2019-2024) & (US$ Million)
    Table 42. Asia-Pacific Clotting Factor Market Size by Region (2025-2030) & (US$ Million)
    Table 43. Latin America Clotting Factor Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Latin America Clotting Factor Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Latin America Clotting Factor Market Size by Country (2025-2030) & (US$ Million)
    Table 46. Middle East & Africa Clotting Factor Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 47. Middle East & Africa Clotting Factor Market Size by Country (2019-2024) & (US$ Million)
    Table 48. Middle East & Africa Clotting Factor Market Size by Country (2025-2030) & (US$ Million)
    Table 49. Amgen Company Detail
    Table 50. Amgen Business Overview
    Table 51. Amgen Clotting Factor Product
    Table 52. Amgen Revenue in Clotting Factor Business (2019-2024) & (US$ Million)
    Table 53. Amgen Recent Development
    Table 54. Novartis Company Detail
    Table 55. Novartis Business Overview
    Table 56. Novartis Clotting Factor Product
    Table 57. Novartis Revenue in Clotting Factor Business (2019-2024) & (US$ Million)
    Table 58. Novartis Recent Development
    Table 59. Baxter Company Detail
    Table 60. Baxter Business Overview
    Table 61. Baxter Clotting Factor Product
    Table 62. Baxter Revenue in Clotting Factor Business (2019-2024) & (US$ Million)
    Table 63. Baxter Recent Development
    Table 64. Britannia Company Detail
    Table 65. Britannia Business Overview
    Table 66. Britannia Clotting Factor Product
    Table 67. Britannia Revenue in Clotting Factor Business (2019-2024) & (US$ Million)
    Table 68. Britannia Recent Development
    Table 69. Capricor Company Detail
    Table 70. Capricor Business Overview
    Table 71. Capricor Clotting Factor Product
    Table 72. Capricor Revenue in Clotting Factor Business (2019-2024) & (US$ Million)
    Table 73. Capricor Recent Development
    Table 74. CSL Behring Company Detail
    Table 75. CSL Behring Business Overview
    Table 76. CSL Behring Clotting Factor Product
    Table 77. CSL Behring Revenue in Clotting Factor Business (2019-2024) & (US$ Million)
    Table 78. CSL Behring Recent Development
    Table 79. GlaxoSmithKline Company Detail
    Table 80. GlaxoSmithKline Business Overview
    Table 81. GlaxoSmithKline Clotting Factor Product
    Table 82. GlaxoSmithKline Revenue in Clotting Factor Business (2019-2024) & (US$ Million)
    Table 83. GlaxoSmithKline Recent Development
    Table 84. Grifol Company Detail
    Table 85. Grifol Business Overview
    Table 86. Grifol Clotting Factor Product
    Table 87. Grifol Revenue in Clotting Factor Business (2019-2024) & (US$ Million)
    Table 88. Grifol Recent Development
    Table 89. Eli Lilly Company Detail
    Table 90. Eli Lilly Business Overview
    Table 91. Eli Lilly Clotting Factor Product
    Table 92. Eli Lilly Revenue in Clotting Factor Business (2019-2024) & (US$ Million)
    Table 93. Eli Lilly Recent Development
    Table 94. Research Programs/Design for This Report
    Table 95. Key Data Information from Secondary Sources
    Table 96. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Clotting Factor Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Clotting Factor Market Share by Type: 2023 VS 2030
    Figure 3. Clotting Factor I Features
    Figure 4. Clotting Factor II Features
    Figure 5. Clotting Factor III Features
    Figure 6. Clotting Factor IV Features
    Figure 7. Others Features
    Figure 8. Global Clotting Factor Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 9. Global Clotting Factor Market Share by Application: 2023 VS 2030
    Figure 10. Hospitals Case Studies
    Figure 11. Clinics Case Studies
    Figure 12. Ambulatory Surgical Centers Case Studies
    Figure 13. Clotting Factor Report Years Considered
    Figure 14. Global Clotting Factor Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 15. Global Clotting Factor Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Clotting Factor Market Share by Region: 2023 VS 2030
    Figure 17. Global Clotting Factor Market Share by Players in 2023
    Figure 18. Global Top Clotting Factor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clotting Factor as of 2023)
    Figure 19. The Top 10 and 5 Players Market Share by Clotting Factor Revenue in 2023
    Figure 20. North America Clotting Factor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. North America Clotting Factor Market Share by Country (2019-2030)
    Figure 22. United States Clotting Factor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada Clotting Factor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Clotting Factor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Clotting Factor Market Share by Country (2019-2030)
    Figure 26. Germany Clotting Factor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. France Clotting Factor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. U.K. Clotting Factor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Italy Clotting Factor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Russia Clotting Factor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Nordic Countries Clotting Factor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Asia-Pacific Clotting Factor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Asia-Pacific Clotting Factor Market Share by Region (2019-2030)
    Figure 34. China Clotting Factor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Japan Clotting Factor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. South Korea Clotting Factor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Southeast Asia Clotting Factor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. India Clotting Factor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Australia Clotting Factor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Latin America Clotting Factor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Latin America Clotting Factor Market Share by Country (2019-2030)
    Figure 42. Mexico Clotting Factor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Brazil Clotting Factor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Middle East & Africa Clotting Factor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Middle East & Africa Clotting Factor Market Share by Country (2019-2030)
    Figure 46. Turkey Clotting Factor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Saudi Arabia Clotting Factor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Amgen Revenue Growth Rate in Clotting Factor Business (2019-2024)
    Figure 49. Novartis Revenue Growth Rate in Clotting Factor Business (2019-2024)
    Figure 50. Baxter Revenue Growth Rate in Clotting Factor Business (2019-2024)
    Figure 51. Britannia Revenue Growth Rate in Clotting Factor Business (2019-2024)
    Figure 52. Capricor Revenue Growth Rate in Clotting Factor Business (2019-2024)
    Figure 53. CSL Behring Revenue Growth Rate in Clotting Factor Business (2019-2024)
    Figure 54. GlaxoSmithKline Revenue Growth Rate in Clotting Factor Business (2019-2024)
    Figure 55. Grifol Revenue Growth Rate in Clotting Factor Business (2019-2024)
    Figure 56. Eli Lilly Revenue Growth Rate in Clotting Factor Business (2019-2024)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS